Neena Bitritto-Garg's Stock Coverage
| IRLAIRulya Therapeutics | ― | ― | ― | ― | 1Ratings | +57.70% | ||
| AMLXAmylyx Pharmaceuticals Inc | Apr 04, 2024 | BUY | Reiterated | $4.00 | 15Ratings | -4.51% | ||
| ROIVRoivant Sciences | Apr 03, 2024 | BUY | Reiterated | $15.00 | 9Ratings | +45.94% | ||
| SRPTSarepta Therapeutics | Feb 29, 2024 | BUY | Reiterated | $156.00 | 12Ratings | +13.62% | ||
| ACADACADIA Pharmaceuticals | Feb 28, 2024 | HOLD | Reiterated | $24.00 | 23Ratings | -15.66% | ||
| NBIXNeurocrine | Feb 07, 2024 | BUY | Reiterated | $161.00 | 13Ratings | +12.79% | ||
| PRTAProthena | Dec 11, 2023 | BUY | Initiated | $62.00 | 9Ratings | -11.39% | ||
| NMRANeumora Therapeutics, Inc. | Dec 11, 2023 | HOLD | Initiated | $13.00 | 1Ratings | ― | ― | |
| IMVTImmunovant | Dec 11, 2023 | BUY | Initiated | $50.00 | 1Ratings | -27.30% | ||
| CMPSCOMPASS Pathways | Dec 11, 2023 | BUY | Initiated | $16.00 | 6Ratings | -57.98% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Neena Bitritto-Garg activity FAQ
What is the performance of Neena Bitritto-Garg's recommendations?
The percentage of profitable recommendations made by Neena Bitritto-Garg is 42.34%, and the average return per transaction is 2.80%.
What stocks does Neena Bitritto-Garg cover?
Neena Bitritto-Garg mostly covers Amylyx Pharmaceuticals Inc, Roivant Sciences, Sarepta Therapeutics stocks.
What was Neena Bitritto-Garg's most profitable rating?
Neena Bitritto-Garg’s most profitable rating was a buy on LBPH stock on Mar 03, 2023. The return on the trade was 310.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here